Related Experiment Video
Updated: Jan 24, 2026

Experience is Instrumental in Tuning a Link Between Language and Cognition: Evidence from 6- to 7- Month-Old Infants' Object Categorization
Published on: April 19, 2017
Topical scabies therapy with permethrin is effective and well tolerated in infants younger than two months
Johanna Charlotte Hoffmann1, Rotraut Mößner1, Michael Peter Schön1
1Department of Dermatology, Venerology und Allergology, Medical Center of University Goettingen, Goettingen, Germany.
Insights
Topical permethrin 5% cream is safe for treating infantile scabies in infants under two months old. This study found the treatment well-tolerated, even with repeated applications, supporting its use in this vulnerable population.
Area of Science:
- Dermatology
- Pediatrics
- Parasitology
Background:
- Infantile scabies requires prompt management to prevent disease spread.
- Limited data exists on topical permethrin 5% cream for infants under two months.
- Current use of permethrin cream in this age group is off-label.
Purpose of the Study:
- To evaluate the safety and efficacy of topical permethrin 5% cream.
- To assess treatment outcomes in infants younger than two months with scabies.
Main Methods:
- Retrospective analysis of seven infants under two months diagnosed with scabies.
- Diagnosis confirmed via clinical symptoms and dermoscopy.
- Evaluation of permethrin 5% cream efficacy and safety.
Main Results:
- Permethrin 5% cream was administered to seven infants.
- Four patients required repeat applications (up to three times) due to incomplete resolution or recurrence.
- The treatment was well-tolerated by all infants.
Conclusions:
- Topical permethrin 5% cream is safe for infants younger than two months.
- The treatment is effective, although repeat applications may be necessary.
- Confirms the safety of permethrin 5% cream for this pediatric age group.
Background And Objectives:
Proper management of infantile scabies is indispensable in order to prevent prolonged duration and spread of the disease. Data are still lacking that support topical treatment with permethrin 5 % cream in infants under two months of age, and application remains off-label for this age group.
Patients And Methods:
We identified infants younger than two months who suffered from scabies in order to evaluate the safety and efficacy of topical treatment with permethrin cream in this age group. Diagnosis of scabies was based on the typical symptoms and pathognomonic features as determined with dermoscopy. We analyzed the efficacy and safety of the therapies that were applied.
Results:
Seven scabies patients under two months of age were treated with permethrin 5 % cream. Topical therapy was repeated up to three times in four patients due to incomplete resolution or recurrence of skin lesions.
Conclusions:
Permethrin therapy was well tolerated in all seven infants, even when conducted several times. Our results confirm that the use of permethrin 5 % cream in children younger than two months of age is safe.
More Related Videos
Related Concept Videos
Gene Therapy
Drug Dosing: Infants and Children
Group Therapy
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects
Psychodynamic Therapy

